N4 Pharma Raises Nets GBP159,700 From Warrant Exercise (ALLISS)

Fri, 09th Mar 2018 10:43

LONDON (Alliance News) - N4 Pharma PLC said Friday it issued 1.9 million shares due to exercise of warrants, raising GBP159,700 for the pharmaceutical company.

The warrants were exercised at 8.5 pence each after the company received notice for their conversion.

Shares in N4 were 2.4% lower at 24.00 pence on Friday.

Admission of the new shares to trading on AIM is expected to take place next Thursday. After admission, N4 will have 91.0 million shares outstanding.

The warrant exercise follows a number of similar transactions in recent weeks.

Related Shares

More News

16 May 2024 15:46

UK shareholder meetings calendar - next 7 days

25 Apr 2024 11:56

N4 Pharma strikes partnership deal for intracellular delivery

(Alliance News) - N4 Pharma PLC on Thursday said it has entered into a collaboration agreement with SRI International Inc.

23 Apr 2024 13:32

IN BRIEF: N4 Pharma loss widens but "great optimism" remains

N4 Pharma PLC - Derbyshire, England-based pharmaceutical company focused on the development of Nuvec - Posts revenue of GBP1,953 in 2023, compared to ...

18 Apr 2024 12:14

N4 Pharma sees potential in Nuvec delivery method for cancer treatment

(Alliance News) - N4 Pharma PLC on Thursday reported that its novel delivery system for cancer treatment has shown promise, after a successful trial.

15 Feb 2024 13:17

N4 Pharma shares jump on latest Nuvec developments

(Sharecast News) - N4 Pharma announced a significant advancement in the development of Nuvec, an innovative delivery system tailored for cancer treatm...